Physician profile
Anita Bhat
NPI 1902068562
$14,833.05
in general payments reported to CMS, 2019-2025
78 companies · $2,600 in 2025
The $2,600 reported for 2025 was more than what 81% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,367 · 2020: $1,348 · 2021: $1,972 · 2022: $2,020 · 2023: $2,212 · 2024: $2,314 · 2025: $2,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,076 · Entertainment: $26.07 · Education: $24.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,076.12 |
| Entertainment | $26.07 |
| Education | $24.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,576.49 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,448.12 | 2019-2025 | Evenity, Tepezza, Prolia |
| Astrazeneca Pharmaceuticals LP | $1,181.64 | 2019-2025 | Fasenra, Tezspire, Farxiga |
| Lilly USA, LLC | $1,115.75 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $879.52 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $816.72 | 2019-2025 | Jardiance, Spiriva |
| Sanofi-Aventis U.S. LLC | $706.64 | 2019-2025 | |
| Glaxosmithkline, LLC. | $501.81 | 2019-2025 | Nucala, Shingrix, Arexvy |
| Radius Health, INC. | $473.96 | 2019-2025 | Tymlos |
| Novartis Pharmaceuticals Corporation | $447.18 | 2022-2025 | |
| Mannkind Corporation | $430.43 | 2019-2025 | Afrezza |
| Medtronic, INC. | $317.16 | 2021-2025 | Inpen Smart Insulin Delivery System, Minimed 780g, Inceptiv |
| Alexion Pharmaceuticals, INC. | $315.16 | 2019-2024 | Strensiq |
| Xeris Pharmaceuticals, INC. | $293.03 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Corcept Therapeutics | $273.61 | 2019-2025 | Korlym |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $226.56 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Merck Sharp & Dohme LLC | $189.56 | 2019-2021 | |
| Abbott Laboratories | $186.36 | 2019-2025 | Freestyle Libre 3 |
| Ibsa Pharma INC. | $185.00 | 2019-2023 | Tirosint, Licart |
| Abbvie INC. | $184.93 | 2019-2022 | |
| Madrigal Pharmaceuticals | $181.77 | 2025 | Rezdiffra |
| Recordati_rare_diseases_inc. | $173.84 | 2024-2025 | Isturisa, Signifor Lar |
| Insulet Corporation | $167.30 | 2019-2024 | Omnipod |
| Pfizer INC. | $164.24 | 2020-2025 | |
| Horizon Therapeutics Plc | $135.74 | 2021-2022 | |
| Exact Sciences Corporation | $114.58 | 2024-2025 | Cologuard Collection Kit |
| Intra-Sana Laboratories | $113.84 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Regeneron Healthcare Solutions, INC. | $106.74 | 2019-2025 | Dupixent |
| Dexcom, INC. | $103.33 | 2022-2024 | Dexcom G6 Transmitter |
| Echosens North America, INC. | $98.72 | 2023 | Fibroscan |
| Genzyme Corporation | $84.39 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.63 | 2022-2023 | Takhzyro |
| Biohaven Pharmaceutical Holding Company LTD. | $76.01 | 2022 | |
| Kaleo, INC. | $75.39 | 2019-2023 | Auvi-Q |
| Companion Medical, INC. | $75.09 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $68.99 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $58.89 | 2019 | |
| Kyowa Kirin, INC. | $58.08 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $57.50 | 2021-2022 | |
| Esperion Therapeutics, INC. | $51.10 | 2021-2024 | Nexletol |
| Ascendis Pharma Endocrinology INC | $50.67 | 2023-2025 | Yorvipath |
| Sandoz INC. | $45.83 | 2025 | Jubbonti |
| Medtronic Minimed, INC. | $42.77 | 2020 | |
| Optinose US, INC. | $41.83 | 2020-2021 | |
| Sanofi Pasteur INC. | $41.22 | 2023 | |
| Genentech USA, INC. | $38.68 | 2020-2025 | Xolair |
| Octapharma USA, INC. | $37.93 | 2019 | |
| Zealand Pharma US, INC. | $36.10 | 2021 | |
| Averitas Pharma INC. | $35.87 | 2024 | Qutenza |
| Globus Medical, INC. | $34.14 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $33.93 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $31.46 | 2025 | Rexulti |
| Amryt Pharma Holdings LTD | $28.75 | 2022 | |
| Fresenius Kabi USA, LLC | $28.50 | 2025 | |
| Axsome Therapeutics, INC. | $27.48 | 2024 | Sunosi |
| Becton, Dickinson and Company | $26.45 | 2021 | |
| Biocryst US Sales Co., LLC | $26.31 | 2023 | Orladeyo |
| Optos, INC. | $26.07 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Astellas Pharma US INC | $25.97 | 2023 | Veozah |
| Rhythm Pharmaceuticals, INC. | $25.90 | 2025 | Imcivree |
| Almatica Pharma LLC | $23.93 | 2025 | Teriparatide |
| Sequel Med Tech, LLC | $23.04 | 2025 | Twiist |
| Greer Laboratories, INC. | $23.00 | 2024 | Oralair |
| Shire North American Group INC | $22.66 | 2019 | |
| Cipher Pharmaceuticals US LLC | $22.47 | 2025 | Spinosad, Natroba |
| Amphastar Pharmaceuticals, INC. | $22.24 | 2025 | |
| Clarus Therapeutics INC. | $22.17 | 2021 | |
| Rgh Enterprises LLC | $21.83 | 2023 | |
| Ferring Pharmaceuticals INC. | $21.45 | 2020 | |
| Cequr Corporation | $18.60 | 2022 | |
| Tandem Diabetes Care, INC. | $17.85 | 2022 | |
| Irhythm Technologies, INC. | $16.93 | 2020 | |
| Currax Pharmaceuticals LLC | $16.74 | 2023 | Onzetra Xsail, Contrave |
| Seqirus USA INC | $16.45 | 2025 | Flucelvax, Fluad |
| Janssen Pharmaceuticals, INC | $16.39 | 2019 | |
| Amarin Pharma, INC. | $16.35 | 2020 | |
| Bigfoot Biomedical INC | $15.95 | 2021 | |
| Agepha Pharma Fz LLC | $14.34 | 2025 | Lodoco |
Drugs and devices associated with these payments
Ilet Bionic Pancreas $680Jardiance $626Kerendia $583Fasenra $356Leqvio $347Rybelsus $317Ozempic $317Evenity $268Tepezza $252Zepbound $249Mounjaro $243Afrezza $221Tzield $210Wegovy $185Prolia $184Rezdiffra $182Tirosint $180Isturisa $174Strensiq $125Dupixent $122Ilet Insulin Infusion Kit Contact Detach $117Ilet Insulin Infusion Kit Inset $117Reltone 400 Mg $114Glycate $114Reltone 200 Mg $114Gvoke Hypopen $112Repatha $100Tezspire $99.92Paxlovid $98.88Fibroscan $98.72Licart $89.93Omnipod $88.13Inpen Smart Insulin Delivery System $84.48Nucala $76.19Minimed 780g $75.69Cologuard Collection Kit $72.22Freestyle Libre 3 $68.36Trulicity $68.06Shingrix $66.19Farxiga $59.66Crysvita $58.08Arexvy $57.78Inceptiv $56.85Xolair $55.09Dexcom G6 Transmitter $54.45Takhzyro $54.07Oct Ophthalmoscope $52.14Panoramic Ophthalmoscope $52.14Tymlos $50.25Fluzone Quadrivalent Northern Hemisphere $49.28Flublok Quadrivalent Northern Hemisphere $41.22Nurtec Odt $40.17Recorlev $39.99Toujeo $39.68Qutenza $35.87Prevnar 20 $35.80Comirnaty $35.80Senza $34.14Soliqua 100/33 $32.96Trelegy Ellipta $32.05Rexulti $31.46Signifor Lar $28.69Sunosi $27.48Otezla $26.33Orladeyo $26.31Nfc-700 $26.07Veozah $25.97Imcivree $25.90Korlym $25.17Yorvipath $24.81Emgality $24.55Rhapsido $24.01Teriparatide $23.93Twiist $23.04Oralair $23.00Nexletol $22.88Abrysvo $22.69Natroba $22.47Spinosad $22.47Auvi-Q $22.10Zavzpret $16.98Onzetra Xsail $16.74Contrave $16.74Fluad $16.45Flucelvax $16.45Jubbonti $15.49Spiriva $15.14Lyumjev $14.81Lodoco $14.34
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anita Bhat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.